A-share Announcement Highlights | Shenzhen Kinwong Electronic (603228.SH): Q3 net profit expected to increase 205%-265% year-on-year.
Kinwong Electronic announced that it expects net profit attributable to shareholders of the listed company for the third quarter of 2026 to be RMB 912 million1.089 billion, up 205.46%264.74% year-on-year.
Today's Focus
1. Shenzhen Kinwong Electronic: Q3 net profit expected to increase 205%-265% year-on-year, high-performance PCB mass production and delivery accelerating in high-speed communication and AI data infrastructure sectors
Shenzhen Kinwong Electronic announced that it expects net profit attributable to shareholders of the listed company for Q3 2026 to be RMB 912 million1.089 billion, up 205.46%264.74% year-on-year. The performance change is mainly due to accelerated mass production and delivery of high-performance PCBs in high-speed communication and AI data infrastructure sectors, combined with order structure optimization and multiple internal cost reduction and efficiency enhancement measures, resulting in rapid growth in both operating revenue and net profit. As of the end of the reporting period, the company has a full order book in AI servers and data centers, and high-speed optical modules, with high capacity utilization and yield rates, and the company is fully committed to meeting delivery targets.
2. China Jushi Co., Ltd: Net profit for the first three quarters of 2026 expected to increase 100% to 110% year-on-year
China Jushi Co., Ltd announced that it expects net profit attributable to shareholders of the listed company for the first three quarters of 2026 to be RMB 5.136 billion to 5.393 billion, up 100% to 110% year-on-year; non-recurring net profit to be RMB 5.225 billion to 5.486 billion, up 100% to 110% year-on-year. Net profit for the same period last year was RMB 2.568 billion, and non-recurring net profit was RMB 2.612 billion. The performance growth is mainly due to increased downstream demand for fiberglass and rising volumes and prices of products.
3. Shenzhen hongfuhan Technology: Net profit for the first three quarters expected to increase 108%-145% year-on-year, liquid cooling full-cabinet module business in mass production and delivery, capacity gradually being released
Shenzhen hongfuhan Technology announced that it expects net profit attributable to shareholders of the listed company for the first three quarters of 2026 to be RMB 170 million200 million, up 108.19%144.93% year-on-year. The company's profit growth in Q3 was mainly driven by two aspects: first, the liquid cooling full-cabinet module business, a key focus area, completed mass production and delivery, with liquid cooling plate module capacity gradually being released, becoming the core incremental driver of profit growth for the period; second, traditional existing businesses such as consumer electronics precision functional components and automation equipment steadily expanded sales scale, with existing businesses maintaining stable operations, providing solid support for profits.
4. DELTON: Net profit for the first three quarters expected to increase 100%-107% year-on-year, focusing on the computing power PCB market with steady performance improvement
DELTON announced that it expects net profit attributable to shareholders of the listed company for the first three quarters of 2026 to be RMB 1.45 billion1.5 billion, up 100.33%107.23% year-on-year; non-recurring net profit to be RMB 1.42 billion to 1.47 billion, up 101.84% to 108.94% year-on-year. The performance change is mainly due to the company seizing market opportunities brought by surging demand for computing hardware, firmly focusing on the computing power PCB market for general-purpose servers, AI servers, switching products, and accelerator cards, with operating performance steadily improving; the overseas factory Thailand Guanghe completed core customer certification, with capacity gradually being released and achieving profitability during the reporting period; subsidiary Huangshi Guanghe continued to promote cost control and product structure optimization, with profitability improving year-on-year.
5. Fujian Newchoice Pipe Technology: 2023 annual report suspected of information disclosure violations, filed for investigation by the CSRC
Fujian Newchoice Pipe Technology announced that the company received a filing notice from the CSRC, and the CSRC decided to file a case against the company for suspected information disclosure violations in its 2023 annual report. During the investigation period, the company will actively cooperate with the investigation work and strictly fulfill its information disclosure obligations.
6. Zhejiang Sunriver Culture Tourism: Actual controller Yu Faxiang filed for investigation due to suspected information disclosure violations
Zhejiang Sunriver Culture Tourism announced that on October 9, 2026, the company's actual controller Yu Faxiang received a "Filing Notice" issued by the China Securities Regulatory Commission, and the CSRC decided to file a case against him for suspected personal information disclosure violations. Yu Faxiang does not hold any position in the company, the company's production and operations are all normal, and the above matter will not have a material impact on the company's normal production and operations.
7. Wuliangye Yibin: Cumulative repurchase of 16,127,800 shares, total amount paid approximately RMB 1.2 billion
Wuliangye Yibin announced that as of September 30, 2026, the company has cumulatively repurchased 16,127,800 shares, accounting for 0.4155% of total share capital, with the highest transaction price at RMB 85.25/share and the lowest at RMB 70.28/share, with total amount paid approximately RMB 1.201 billion.
8. Biwin Storage Technology: As of September 30, 2026, cumulative repurchase of RMB 222 million
Biwin Storage Technology announced that as of September 30, 2026, the company has cumulatively repurchased 1,044,700 shares through centralized bidding transactions, accounting for 0.22% of total share capital, with repurchase transaction price range of RMB 211.01/share to RMB 214.05/share, and total funds paid of RMB 222 million. The expected repurchase amount for this repurchase plan is RMB 200 million to 250 million, with the repurchase period from August 27, 2026 to August 26, 2027.
9. Luxshare Precision Industry: No overseas control-related matters found to have caused material adverse impact on the company's overall production and operations
Luxshare Precision Industry announced that the company's current production and operations are normal, with main businesses and orders progressing in an orderly manner according to customer demand, and there is no major undisclosed information that should be disclosed. Regarding matters of market concern such as overseas controls, the company continues to monitor relevant policies and supply chain changes, and actively ensures supply chain security and business response. Currently, no related matters have been found to have caused material adverse impact on the company's overall production and operations.
10. China Northern Rare Earth: Q4 2026 rare earth concentrate transaction price adjusted to RMB 38,800/ton excluding tax, up 0.53% quarter-on-quarter
China Northern Rare Earth announced that according to the rare earth concentrate pricing method and Q3 2026 rare earth oxide prices, after calculation and approval by the company's 20th general manager's office meeting of 2026, the company's Q4 2026 rare earth concentrate transaction price is adjusted to RMB 38,769/ton excluding tax (dry basis, REO=50%), with the price excluding tax increasing or decreasing by RMB 775.38/ton for each 1% change in REO.
11. Inner Mongolia BaoTou Steel Union: Q4 rare earth concentrate transaction price proposed to be adjusted to RMB 38,800/ton, up 0.53% quarter-on-quarter
Inner Mongolia BaoTou Steel Union announced that according to the rare earth concentrate price adjustment mechanism and calculation formula approved by the company's 2022 annual general meeting of shareholders, the company proposes to adjust the Q4 2026 rare earth concentrate related-party transaction price to RMB 38,769/ton excluding tax (dry basis, REO=50%), with the price excluding tax increasing or decreasing by RMB 775.38/ton for each 1% change in REO.
12. Shanghai Zizhu High-Tech Science And Technology: Aluminum-plastic film products for lithium batteries and solid-state battery concept-related business still in early exploration and R&D stage
Shanghai Zizhu High-Tech Science And Technology issued an abnormal fluctuation announcement stating that the company has noticed that the "solid-state battery" related concept has recently received widespread market attention. As of now, the company's aluminum-plastic film products for lithium batteries and business related to the above concept are still in the early exploration and R&D stage. There is significant uncertainty regarding when productization can be achieved and provide the company with stable large-scale revenue. Investors are kindly requested to pay full attention to the above uncertainties, invest rationally, and be aware of investment risks.
13. North China Pharmaceutical: Company's streptomycin sulfate for injection sales revenue scale is relatively small
North China Pharmaceutical issued a stock trading abnormal fluctuation announcement stating that the company has noticed recent high market attention on "plague" related hot concepts. Upon verification, the company's streptomycin sulfate for injection instructions show that its indications include being used alone for the treatment of tularemia, or in combination with other antibacterial drugs for the treatment of plague, inguinal granuloma, brucellosis, rat-bite fever, etc. This product is a traditional antibiotic variety of the company, and its sales revenue scale in 2025 and January-June 2026 was relatively small, and will not have a material impact on the company's overall operating performance.
14. Shandong Fengyuan Chemical: Main business is lithium-ion battery cathode material business and oxalic acid business, not involving battery production business
Shandong Fengyuan Chemical issued a stock trading abnormal fluctuation announcement stating that the company has noticed recent high market attention on the solid-state battery concept. Currently, the company's main business is lithium-ion battery cathode material business and oxalic acid business, not involving battery production business, and there is no related business revenue. The company has made forward-looking R&D arrangements in the field of solid-state battery cathode materials and has participated in a solid-state battery production enterprise, but the shareholding ratio is relatively low, not included in the company's consolidated financial statements, and will not have a material impact on the company's current main business and operating performance.
15. Anhui Gourgen Traffic Construction: Actual controller Yu Faxiang received filing notice
Anhui Gourgen Traffic Construction announced that on October 9, 2026, the company's actual controller Yu Faxiang received a "Filing Notice" issued by the China Securities Regulatory Commission, and was filed for investigation due to suspected information disclosure violations. Yu Faxiang does not hold any position in the company, the company's production and operations are all normal, and the above matter will not have a material impact on the company's normal production and operations.
16. MicuRx Pharmaceuticals: Signs MRX-23 exclusive license and platform cooperation agreement with ClearideBio, total milestone payments and other amounts capped at USD 750 million
MicuRx Pharmaceuticals announced that the company plans to sign an MRX-23 project exclusive license agreement and platform technology cooperation agreement with Switzerland-based ClearideBio. The former involves a global exclusive license for the MRX-23 project; the latter is a global option cooperation based on the company's independently developed "STOPIN" antibody-drug conjugate platform with a novel camptothecin payload, and ClearideBio may exercise options for a specified number of target or target combination projects according to the agreement. Under the MRX-23 license agreement, a upfront payment of USD 1 million is payable after the agreement takes effect as agreed, and this payment is non-refundable after payment; near-term development milestone payments are triggered by the first clinical trial application approval for the licensed product. The nominal total of MRX-23 R&D, registration, and sales milestone payments is capped at USD 223 million, and when all platform cooperation projects are exercised and all milestones are achieved, the total payment cap is USD 750 million.
17. Bohai Leasing: Avalon's subsidiary plans to purchase 140 Boeing aircraft, total value not exceeding USD 26.953 billion
Bohai Leasing announced that the company's controlled subsidiary Avalon's wholly-owned subsidiary AALL signed an agreement with Boeing Company to purchase 140 B737MAX series aircraft. Based on Boeing's published catalog prices, the total value corresponding to the aircraft purchased in this transaction does not exceed USD 26.953 billion (aircraft catalog prices include fuselage price, optional equipment price, and engine price, etc.), and the company's actual purchase price has a certain degree of discount on the above catalog prices. This transaction does not constitute a related-party transaction and still needs to be submitted to the shareholders' meeting for approval, with delivery expected to be completed before the end of 2036.
18. Liaoning Shidai Wanheng: Company products do not involve solid-state batteries
Liaoning Shidai Wanheng issued a stock trading risk warning announcement stating that the company's lithium battery products are small-power cylindrical ternary lithium batteries, mainly used in the small electric tools field, with 1865 and 1450 as the two main product categories; nickel-metal hydride battery products are mainly used in personal care, civil consumer goods, electric tools, and other fields. The company's products do not involve solid-state batteries. The company's current production and operations are normal, with production organized according to orders. As of the disclosure date of this announcement, the company's existing main products and production lines have not changed, and the production and operation fundamentals have not undergone major changes.
19. LingNan Eco&Culture-Tourism: Closing price below RMB 1 for nineteen consecutive trading days, facing delisting risk due to par value
LingNan Eco&Culture-Tourism announced that as of October 9, 2026, the company's stock closing price has been below RMB 1 for nineteen consecutive trading days. If it remains below RMB 1 for 20 consecutive trading days, the company's stock will face the risk of being delisted due to stock price below par value, and the company's convertible corporate bonds also face delisting risk. This is the company's eleventh risk warning announcement.
Operating Performance
1. Universal Scientific Industrial(Shanghai)Co.,: September 2026 operating revenue RMB 7.487 billion, up 25.64% year-on-year
2. Xinjiang Tianshan Animal Husbandry Bio-engineering: September 2026 live livestock sales volume 340 head, up 15.65% year-on-year
3. Shandong Yisheng Livestock & Poultry Breeding: September 2026 white-feathered broiler sales volume 55.2233 million birds, up 4.52% year-on-year
4. Ningxia Xiaoming Agriculture & Animal Husbandry: September 2026 chicken product sales volume 21.0524 million birds, down 2.62% year-on-year
5. Dongrui Food Group: September hog sales revenue RMB 177 million, up 7.64% month-on-month
6. Guizhou Panjiang Refined Coal: First three quarters of 2026 commercial coal sales volume down 9.03% year-on-year
7. China Coal Xinji Energy: January-September 2026 power generation up 88.75% year-on-year
8. China National Nuclear Power: First three quarters of 2026 commercial power generation up 1.25% year-on-year
9. Shenzhen Kingsino Technology: September 2026 hog sales volume 108,200 head, down 1.64% year-on-year
10. Jiangxi Zhengbang Technology: September 2026 hog sales volume 842,300 head, up 6.53% year-on-year
11. Shandong Wohua Pharmaceutical: Q3 2026 net profit RMB 25.0882 million, up 29.87% year-on-year
12. Shanghai International Port: September estimated completed home port cargo throughput 53.467 million tons, up 2.3% year-on-year
13. Tangshan Port Group: January-September estimated cumulative completed cargo throughput 189 million tons, up 5.06% year-on-year
14. Ningbo Zhoushan Port: September estimated completed cargo throughput 106 million tons, up 1% year-on-year
15. China Longyuan Power Group Corporation: September completed power generation 566.66 MWh on a consolidated basis
16. Kunshan GLVAC Electronic Technology: Q3 2026 net profit expected to increase 35.11%-62.13% year-on-year
17. Jiangte Equipment: Application for A-share issuance to specific targets accepted by SSE
18. Suzhou Industrial Park Heshun Electric: Plans to sell 84.52% equity of Zhongdao Electric for RMB 77.96 million
19. Shenzhen Absen Optoelectronic: First three quarters of 2026 net profit expected to increase 32.31%-43.11% year-on-year
20. Kunming Chuan Jin Nuo Chemical: First three quarters of 2026 net profit expected to decrease 40.87%-47.44% year-on-year
21. Guangdong Shaoneng Group: First three quarters of 2026 net profit expected to increase 61.12%-75.03% year-on-year
22. Henan Shuanghui Investment & Development: Administrative penalty to reduce 2026 net profit by RMB 63.8066 million
Abnormal Fluctuation Risk Warnings
1. Shandong Fengyuan Chemical: Main business is lithium-ion battery cathode material business and oxalic acid business, not involving battery production business
2. Anhui Gourgen Traffic Construction: Actual controller Yu Faxiang received filing notice
3. ST Nachuan: Received CSRC filing notice on October 9, 2026
4. Zhejiang Sunriver Culture Tourism: Actual controller Yu Faxiang filed for investigation due to suspected information disclosure violations
5. North China Pharmaceutical: Company's streptomycin sulfate for injection sales revenue scale is relatively small
6. Shanghai Zizhu High-Tech Science And Technology: Aluminum-plastic film products for lithium batteries and solid-state battery concept-related business still in early exploration and R&D stage
7. Jiangsu Gdk Biological Technology: Trivalent influenza vaccine obtained drug registration certificate, full-year revenue may be below RMB 100 million and may trigger delisting risk warning
8. Guilin Tourism Corporation: Wholly-owned subsidiary suspended operations
9. ST Lingnan: Company's illegal subcontracting proposed fine of RMB 1.0589 million
10. Shanghai Xinhua Media: If company stock price further abnormally rises, may apply for trading suspension for verification
Repurchases & Increases/Decreases in Holdings
1. Hangzhou AGS Medtech: Plans to repurchase company shares for RMB 35 million to 70 million
2. Hangzhou Lion Microelectronics: Plans to publicly transfer 3.6221% equity of Jinruihong
3. Kingclean Electric: Plans to register and issue RMB 2 billion ultra-short-term financing bonds
4. Hangzhou Hikvision Digital Technology: Controlling shareholder's concert party CETC Investment plans non-public issuance of no more than RMB 2 billion exchangeable corporate bonds
5. Jinjian Cereals Industry: Xinzhongyi Company's annual 30,000-ton jelly project investment increased by RMB 4.49 million
6. Ningxia Younglight Chemicals: Controlling shareholder plans to publicly solicit transferees for 39.41% shares
7. Nanjing Sciyon Wisdom Technology Group: Plans to transfer 70% equity and claims of controlling subsidiary Lingbi Guozhen for RMB 35 million
8. ZERUN CO., LTD: Plans to acquire no less than 51% equity of Hechuang Intelligent Manufacturing, quickly entering the heat pipe industry
9. Yunnan Energy Investment: Subsidiary plans to invest RMB 353 million to build Malu photovoltaic power generation project
10. Soho Holly Corporation: Plans to sell no more than 4.4 million Soho Holly Futures A-shares
11. DATANG POWER: Plans to increase capital by RMB 628 million in Datang Nuclear Power Company
12. Guangdong Aofei Data Technology: Actual controller proposes repurchase of RMB 50 million to 100 million shares
13. Shanghai Fullhan Microelectronics: Subsidiary Xinhan Zhixing introduces Hanlian Fund capital increase of RMB 88 million
14. Sungrow Power Supply: Cumulative repurchase of 3,047,600 shares, spending RMB 325 million
15. Huasu Holdings: Plans to acquire 51% equity of Ningxia Junfeng for RMB 23.7048 million
16. Hainan Mining: Controlling shareholder plans to transfer 5% shares by agreement for RMB 901 million
17. Changzheng Engineering Technology: Controlling subsidiary plans to acquire 45% equity of Xinxiang Gas for RMB 191 million
18. BBMG: Government plans to acquire three land parcels of wholly-owned subsidiary for RMB 1.948 billion
19. Chaozhou Three-Circle(Group): Spent RMB 995 million to repurchase 0.43% shares
20. Jiangsu Rongtai Industry: Controlling shareholder plans to transfer 6% shares by agreement
21. Jiangsu Dagang: Plans to list and transfer 16% equity of Suzhou Keyang for RMB 200 million
22. TCL Zhonghuan Renewable Energy Technology: Cumulative repurchase of 42,402,100 shares, total transaction amount RMB 4.2 billion
23. SMS Electric: Yu Wenbiao and Zhoushan Henghui plan to reduce holdings by no more than 1% and 2% shares
24. Jiangxi Synergy Pharmaceutical: Pang Zhengwei increased holdings by 61,800 shares, shareholding ratio rose to 29.05%
25. Ledman Optoelectronic: Sale of 8,390,200 repurchased shares, plan implementation completed
Major Contracts
1. Yangzhou Huitong Technology Corp.,: Won bid for RMB 366 million polyester chemical fiber project
2. Nanjing Wondux Environmental Protection Technology Corp., Ltd.: Company won bid for RMB 114 million entrusted operation and maintenance service project
3. China Merchants Shekou Industrial Zone Holdings: September achieved contracted sales amount RMB 14.322 billion
4. Bohai Leasing: Subsidiary Avalon's subsidiary signs agreement with Airbus, plans to purchase 110 next-generation technology aircraft
5. Fulai Huite: Wholly-owned subsidiary signs RMB 919 million service agreement
6. Gansu Energy Chemical: Subsidiaries win bids for multiple projects
7. JinGuan Electric: Wholly-owned subsidiary signs EPC general contracting framework agreement not exceeding USD 296 million
8. Wuhan Tianyuan Group: Signs RMB 195 million energy storage power station project contract
9. Guohai Co., Ltd.: Won bid for embankment treatment project, amount RMB 162 million
This article is reprinted from "Tencent Stock Picker", GMTEight editor: Xu Wenqiang.
Related Articles

BOAN BIOTECH (06955) Enters into a Promotion Cooperation Agreement with Nanjing Luye

BRII-B (02137) repurchased 101,000 shares for HK$85,000 on October 9.

Morgan Stanley is bullish on the AI semiconductor rally: TSMC offers strong certainty, while ACM Research and Silicon Motion have over 50% upside to their price targets.
BOAN BIOTECH (06955) Enters into a Promotion Cooperation Agreement with Nanjing Luye

BRII-B (02137) repurchased 101,000 shares for HK$85,000 on October 9.

Morgan Stanley is bullish on the AI semiconductor rally: TSMC offers strong certainty, while ACM Research and Silicon Motion have over 50% upside to their price targets.






